BSF Enterprise Plc (BSFAF)
OTCMKTS · Delayed Price · Currency is USD
0.0300
0.00 (0.00%)
At close: Feb 3, 2026
BSF Enterprise Market Cap
BSF Enterprise has a market cap or net worth of $3.15 million as of February 12, 2026. Its market cap has decreased by -31.56% in one year.
Market Cap
3.15M
Enterprise Value
2.94M
Revenue
71.03K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.03
Market Cap Chart
Since July 26, 2019, BSF Enterprise's market cap has increased from 1.26M to 3.15M, an increase of 149.88%. That is a compound annual growth rate of 14.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 3.15M | -4.11% |
| Dec 31, 2025 | 3.28M | -10.48% |
| Dec 31, 2024 | 3.67M | -72.82% |
| Dec 29, 2023 | 13.49M | -22.07% |
| Dec 30, 2022 | 17.31M | 731.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bioxytran | 5.30M |
| AXIM Biotechnologies | 4.99M |
| Enzon Pharmaceuticals | 4.79M |
| Burzynski Research Institute | 4.47M |
| Nymox Pharmaceutical | 4.08M |
| Vaccinex | 3.99M |
| Clearside Biomedical | 3.57M |
| Enzolytics | 2.66M |